Загрузка...
Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia
5-Hydroxytryptamine type 2 antagonists are used to treat symptomatic peripheral arterial disease. However, it remains unknown as to whether the administration of sarpogrelate, a 5-hydroxytryptamine type 2 antagonist, improves the prognosis after endovascular therapy for critical limb ischemia (CLI)....
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Japan
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4085500/ https://ncbi.nlm.nih.gov/pubmed/23494607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00380-013-0334-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|